Efficacy and Safety of Probiotics, Prebiotics and Synbiotics for the Prevention of Colorectal Cancer and Precancerous Lesion in High‐risk Populations: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

Author:

Kan Haoxuan12,Cao Yang12ORCID,Ma Ye12,Zhang Yuelun3,Wang Jing1,Li Ji1,Li Jingnan1

Affiliation:

1. Department of Gastroenterology, Key Laboratory of Gut Microbiota Translational Medicine Research, Chinese Academy of Medical Sciences Peking Union Medical College Hospital Beijing China

2. Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Medical Research Center, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Abstract

AbstractAimColorectal cancer is highly prevalent worldwide and is a leading cause of cancer‐related deaths. Probiotics, prebiotics, and synbiotics have recently garnered attention as preventive measures against colorectal neoplasms. We aimed to analyze and summarize the findings of randomized controlled trials that investigated the effects of probiotics, prebiotics and synbiotics on patients at high risk of colorectal cancer, specifically, outlining the challenges and future prospects of using probiotics to prevent colorectal tumors and providing evidence for clinical physicians.MethodsPubMed, Embase, and Cochrane Library was searched for relevant studies published before January 7, 2022. Our study selection criteria focused on randomized controlled trials conducted on populations with high risk of colorectal cancer that received probiotics and/or prebiotics and compared them with placebo or another candidate agent. The primary efficacy outcome was the incidence or recurrence of any colorectal neoplasms. Additional efficacy outcomes included the effects on the diversity of gut microbiota and relevant inflammatory biomarkers. Safety outcomes were also included. Two authors independently screened and selected studies based on prespecified inclusion. They also performed data extraction and risk‐of‐bias assessment independently.ResultsNine randomized controlled trials met our inclusion criteria. Probiotics supplementation significantly reduced adenoma incidence, but no significant difference was observed in colorectal cancer incidence. Additionally, probiotics modulated the gut microbiota and inflammatory factors.ConclusionsProbiotics may have beneficial effects in colorectal cancer prevention, particularly in the adenoma stage. However, more clinical trials with larger sample sizes are required to confirm these findings.This article is protected by copyright. All rights reserved.

Publisher

Wiley

Subject

Gastroenterology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3